Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil

被引:12
|
作者
Maffazioli, Giovana D. N. [1 ]
Lopes, Caroline P. [1 ]
Heinrich-Oliveira, Vanessa [1 ]
Lobo, Rogerio A. [2 ]
Hayashida, Sylvia A. Y. [1 ]
Soares, Jose Maria, Jr. [1 ]
Maciel, Gustavo A. R. [1 ]
Baracat, Edmund C. [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Disciplina Ginecol,Dept Obstet & Ginecolo, Sao Paulo, Brazil
[2] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA
基金
巴西圣保罗研究基金会;
关键词
Diabetes; Dyslipidemia; Hyperinsulinemia; Metabolic syndrome; Metabolism; Polycystic ovary syndrome; INSULIN-RESISTANCE; DIFFERENT PHENOTYPES; CARDIOVASCULAR RISK; ROTTERDAM CRITERIA; GENOMIC ANCESTRY; SYNDROME PCOS; ASSOCIATION; GLUCOSE; OBESITY; HYPERANDROGENISM;
D O I
10.1002/ijgo.13374
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To describe the prevalence of metabolic disturbances in a large cohort of women with polycystic ovary syndrome (PCOS) in southeastern Brazil and to compare the findings with other cohorts of Brazilian women with PCOS. Methods A retrospective study analyzing clinical and laboratory data of 462 women with PCOS treated at an outpatient clinic in a tertiary hospital in southeastern Brazil. Prevalence of insulin resistance, glucose intolerance, type 2 diabetes, dyslipidemia, central obesity, hypertension, and metabolic syndrome was compared to that of other cohorts of age and body mass index-matched Brazilian women with PCOS. Results Women with PCOS had a median age of 25.0 (21.0-29.0) years and BMI of 28.7 (23.9-34.0) kg/m(2). Prevalence of insulin resistance, glucose intolerance, and type 2 diabetes varied from 39.6% to 55.0%, 7.2% to 28.1%, and 2.0% to 4.1%, respectively. Prevalence of central obesity, dyslipidemia due to decreased high-density lipoprotein cholesterol, hypertriglyceridemia, and metabolic syndrome ranged from 57.8% to 66.4%, 54.1% to 70.4%, 22.9% to 35.1%, and 27.4% to 38.3%, respectively, which did not differ among regions in Brazil. Conclusion Prevalence of metabolic disturbances was high among Brazilian women with PCOS. This study suggests that, from a public health perspective, authorities in Brazil should be aware of and encourage screening for metabolic dysfunction in women with PCOS in all regions of the country.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
  • [1] Prevalence of the metabolic syndrome in women with polycystic ovary syndrome
    Bregieiro Fernandes Costa, Laura Olinda
    Ribeiro Viana, Aline de Oliveira
    de Oliveira, Monica
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (01): : 10 - 17
  • [2] Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
    Goverde, A. J.
    van Koert, A. J. B.
    Eijkemans, M. J.
    Knauff, E. A. H.
    Westerveld, H. E.
    Fauser, B. C. J. M.
    Broekmans, F. J.
    HUMAN REPRODUCTION, 2009, 24 (03) : 710 - 717
  • [3] Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome
    Hahn, S.
    Tan, S.
    Sack, S.
    Kimmig, R.
    Quadbeck, B.
    Mann, K.
    Janssen, O. E.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (02) : 130 - 135
  • [4] Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome
    Krentowska, Anna
    Kowalska, Irina
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (01)
  • [5] The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
    Bicer, Nihan Cakir
    Ermis, Asime Aleyna
    Bas, Dilsat
    LIFE-BASEL, 2023, 13 (10):
  • [6] Metabolic syndrome in women with polycystic ovary syndrome: Prevalence, characteristics and predictors
    Marcondes, Jose Antonio M.
    Hayashida, Sylvia A. Y.
    Barcellos, Cristiano R. G.
    Rocha, Michelle P.
    Maciel, Gustavo A. R.
    Baracat, Edmund C.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (06) : 972 - 979
  • [7] Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome
    Fruzzetti, Franca
    Perini, Daria
    Lazzarini, Veronica
    Parrini, Donatella
    Genazzani, Andrea R.
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (05) : 335 - 343
  • [8] Lipid accumulation product is associated with metabolic syndrome in women with polycystic ovary syndrome
    Macut, Djuro
    Antic, Ivana Bozic
    Bjekic-Macut, Jelica
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Milutinovic, Danijela Vojnovic
    Stanojlovic, Olivera
    Kastratovic-Kotlica, Biljana
    Petakov, Milan
    Milic, Natasa
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 15 (01): : 35 - 44
  • [9] Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome
    Chielli Pedroso, Daiana Cristina
    Miranda-Furtado, Cristiana Libardi
    Kogure, Gislaine Satyko
    Meola, Juliana
    Okuka, Maja
    Silva, Celso
    Calado, Rodrigo T.
    Ferriani, Rui Alberto
    Keefe, David L.
    dos Reis, Rosana Maria
    FERTILITY AND STERILITY, 2015, 103 (02) : 542 - 547
  • [10] Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome
    Wen, Xinling
    Wang, Li
    Bai, E.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15